Prestige Consumer Healthcare Inc. (NYSE:PBH) SVP Mary Beth Fritz Sells 2,540 Shares

Prestige Consumer Healthcare Inc. (NYSE:PBHGet Free Report) SVP Mary Beth Fritz sold 2,540 shares of the stock in a transaction on Thursday, September 14th. The shares were sold at an average price of $58.92, for a total transaction of $149,656.80. Following the transaction, the senior vice president now owns 15,934 shares in the company, valued at $938,831.28. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Prestige Consumer Healthcare Trading Down 1.6 %

Shares of NYSE:PBH opened at $57.88 on Friday. Prestige Consumer Healthcare Inc. has a fifty-two week low of $48.51 and a fifty-two week high of $68.54. The firm has a 50-day simple moving average of $61.00 and a 200 day simple moving average of $60.35. The company has a quick ratio of 1.51, a current ratio of 2.66 and a debt-to-equity ratio of 0.89.

Prestige Consumer Healthcare (NYSE:PBHGet Free Report) last posted its earnings results on Thursday, August 3rd. The company reported $1.06 EPS for the quarter, beating the consensus estimate of $1.01 by $0.05. The company had revenue of $279.31 million during the quarter, compared to analyst estimates of $278.79 million. Prestige Consumer Healthcare had a positive return on equity of 13.47% and a negative net margin of 7.46%. The business’s revenue was up .8% compared to the same quarter last year. During the same period in the prior year, the company earned $1.09 earnings per share. On average, sell-side analysts predict that Prestige Consumer Healthcare Inc. will post 4.31 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in PBH. Altshuler Shaham Ltd bought a new stake in Prestige Consumer Healthcare in the fourth quarter valued at $27,000. Natixis acquired a new stake in shares of Prestige Consumer Healthcare in the 4th quarter worth about $36,000. Parallel Advisors LLC lifted its position in Prestige Consumer Healthcare by 74.7% in the 1st quarter. Parallel Advisors LLC now owns 676 shares of the company’s stock valued at $42,000 after purchasing an additional 289 shares during the last quarter. Robeco Institutional Asset Management B.V. acquired a new position in Prestige Consumer Healthcare during the 1st quarter valued at about $59,000. Finally, Global Retirement Partners LLC grew its position in Prestige Consumer Healthcare by 71.5% in the 2nd quarter. Global Retirement Partners LLC now owns 1,113 shares of the company’s stock worth $66,000 after purchasing an additional 464 shares during the last quarter. 99.95% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

PBH has been the topic of several research analyst reports. 3M reaffirmed a “reiterates” rating on shares of Prestige Consumer Healthcare in a research report on Monday, June 26th. TheStreet downgraded Prestige Consumer Healthcare from a “b” rating to a “c+” rating in a report on Thursday, September 7th. Finally, started coverage on Prestige Consumer Healthcare in a report on Thursday, August 17th. They issued a “buy” rating for the company. One analyst has rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $82.00.

View Our Latest Stock Report on PBH

Prestige Consumer Healthcare Company Profile

(Get Free Report)

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

Featured Articles

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with's FREE daily email newsletter.